Compare Northrop Grumman Corporation (NOC) vs Summit Therapeutics Inc (SMMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Northrop Grumman Corporation vs Summit Therapeutics Inc — how do they compare? Northrop Grumman Corporation trades at $512 (market cap $74.42B), while Summit Therapeutics Inc trades at $14.57 (market cap $10.48B). The key difference: Northrop Grumman Corporation is far larger — about 7.1× Summit Therapeutics Inc's market cap, and Northrop Grumman Corporation pays a 1.79% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.
| NOC | SMMT | |
|---|---|---|
Market Cap | $74.42B | $10.48B |
Sector | Industrials | Health |
52-Week High | $768.02 | $29.32 |
52-Week Low | $496.02 | $13.05 |
Enterprise Value | $88.65B | $9.90B |
Dividend Yield | 1.79% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Northrop Grumman Corporation
Northrop Grumman is a defense contractor that is diversified across short-cycle and long-cycle businesses. The firm's segments include aeronautics, mission systems, defense services, and space systems. The company's aerospace segment creates the fuselage for the massive F-35 program and produces various piloted and autonomous flight systems. Mission systems creates a variety of sensors and processors for defense hardware. The defense systems segment is a long-range missile manufacturer. Finally, the company's space systems segment produces various space structures, sensors, and satellites.
Read more on NOC →About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →
